With a background in molecular biomedicine and medical sciences Daniel has worked in the fields of cancer, autoimmune diseases, liver disease, cardiovascular disease and chronic kidney disease. He has been involved in everything from basic research to incorporation of biomarkers in clinical trials. The PhD dissertation focused on tools to quantify the turnover of extracellular matrix components in chronic kidney disease, with a special emphasis on diabetes - the leading cause of chronic kidney disease in the western and industrialized world.